![Hal Broderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hal Broderson
Presidente presso
SansRosa Pharmaceutical Development, Inc.
Profilo
Hal S.
Broderson is the founder of CorBec Pharmaceuticals, Inc. He is currently the President of SansRosa Pharmaceutical Development, Inc. His former positions include Chief Executive Officer at GenVec, Inc., Director at Annovis Bio, Inc., Managing Director at Rock Hill Ventures, Inc., Chief Medical Officer at Agile Therapeutics, Inc., Investment Consultant at The Biotechnology Greenhouse Corp.
of Southeastern PA, and Advisor at Ben Franklin Technology Partners.
Broderson holds an MBA from the University of Pennsylvania and a doctorate from the University of Kentucky.
Posizioni attive di Hal Broderson
| Società | Posizione | Inizio |
|---|---|---|
SansRosa Pharmaceutical Development, Inc.
 SansRosa Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Presidente | - |
Precedenti posizioni note di Hal Broderson
| Società | Posizione | Fine |
|---|---|---|
Rock Hill Ventures, Inc.
 Rock Hill Ventures, Inc. Investment ManagersFinance Rock Hill Ventures focuses on investments in early-stage medical technology companies | Direttore degli Investimenti | 31/12/2009 |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Corporate Officer/Principal | - |
| ANNOVIS BIO, INC. | Direttore/Membro del Consiglio | - |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Investitore di Private Equity | - |
| AGILE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Hal Broderson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
1
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Agile Therapeutics, Inc.
 Agile Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormonal contraceptive products | Health Technology |
Annovis Bio, Inc.
 Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CorBec Pharmaceuticals, Inc.
 CorBec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals designed to modulate the immune system | Health Technology |
Rock Hill Ventures, Inc.
Rock Hill Ventures, Inc. Investment ManagersFinance Rock Hill Ventures focuses on investments in early-stage medical technology companies | Finance |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Finance |
University of Kentucky
 University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SansRosa Pharmaceutical Development, Inc.
SansRosa Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
